Last checked at 10 Nov 2020 07:00
Indivior Announces Participation in Upcoming Investor Conferences
Slough, United Kingdom and Richmond, Virginia - November 10, 2020 - Indivior PLC (LON: INDV) today announced its participation in the following upcoming investor conferences:
· November 16th, 8:00 AM US Eastern Time (ET): Stifel Virtual Healthcare Conference (link).
· November 17th, 12:00 PM US Eastern Time (ET): Jefferies Virtual Global Healthcare Conference (link).
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.
Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
For Further Information
Investor Enquiries
| Jason Thompson | VP, Investor Relations Indivior PLC | +1 804 402 7123 jason.thompson@indivior.com |
Media Enquiries | Jonathan Sibun | Tulchan Communications US Media Inquiries
| +44 207 353 4200 +1 804 594 0836 Indiviormediacontacts@indivior.com |
-ends-